Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > TLT and Competition

<< Previous

Bullboard Posts

Next >>

Comment by enriquesuaveon Nov 25, 2020 8:33am

175 Views

Post# 31968190

RE:RE:RE:RE:RE:TLT and Competition

I'm not sure of the status of Radachlorin, but it may be approved elsewhere. However it is IV infused and they used red light which is not as safe and more side effects overall compared to TLD-1433 which is instilled and uses green light. If they both achieve similar efficacy then TLD-1433 will triumph as it will be most effective and safe controlled procedure. Can't wait for next 13 patients treated, or follow up on 1st 4 with optimized procedure .